Oncotarget

1 stories · following the connections

Business

TRACON Pharmaceuticals Announces Positive Results from Phase 1 Trial of TRC102 and Fludara® in Patients with Advanced Hematologic Malignancy Published in Oncotarget

By Nasdaq OMXNov 13, 2017, 9:05 PM UTC